Polymer Factory Sweden AB announced the launch of the new dendritic platform Dendritic Nanogels (DNG). Through the launch of this platform, the Company fulfills an operational objective set out for 2022. On December 1st, Polymer Factory launched the company's latest dendritic platform, DNG.

This is a nanocarrier platform with the potential use as delivery vehicles of pharmaceuticals, peptides, antibiotics etc. It is a novel platform of crosslinked nanoparticles, with features such as water solubility, biocompatibility, and degradability. The DNGs can be programmed to embed functionality and thereby allow them to act as nanoscopic delivery system of therapeutics, fragrances, peptides, and other organic molecules.

The DNG technology is envisioned to be desired by different industries, particularly for therapeutic, biomedical and industrial use. Polymer Factory has pending patents protecting the novel DNG technology.